Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) TAI
38.20
-0.7(-1.80%)
Currency In TWD
- General
- Statistics
- Historical Data
- Profile
- Financials
38.20
-0.7(-1.80%)
Currency In TWD
Address
No.1, Dongxing Street
New Taipei City, 23850
Taiwan (Province of China)
Phone
886 2 8684 3318
Website
Sector
Healthcare
Industry
Biotechnology
Employees
243
First IPO Date
December 20, 2010
| Name | Title | Pay | Year Born |
| Qing-Peng Wei | General Manager | 0 | N/A |
| Kuan-Chieh Wang | Manager of Finance Department & Head of Corporate Governance | 0 | N/A |
| Jun-Jie Liao | Manager of Human Resource Office | 0 | N/A |
| Guanjie Wang | Accounting Supervisor | 0 | N/A |
| Chao-Sheng Hong | Chief Auditor | 0 | N/A |
Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the research, development, manufacture, and wholesale of active pharmaceutical ingredients (APIs) in Taiwan and the United States. It offers API products, which include immunosuppressant, oncology, cardiovascular, and other products, as well as peptide drugs. The company also develops bulk pharmaceutical products, such as anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular drugs, skeletal, muscle relaxants, hypolipaemics, antineoplastic, antihyperlipedemias, and immunosuppressant products, as well as provides research and development, and contract manufacturing services to new drug developers and generic drug companies. The company was formerly known as China Chemical Synthesis Industry Co., Ltd. Chunghwa Chemical Synthesis & Biotech Co., Ltd. was founded in 1964 and is headquartered in New Taipei City, Taiwan.